Audit in process? Call the number on your audit letter to get options.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
February 9, 2024 - Armas launched an AB-rated generic version of Bausch and Lomb’s Alrex (loteprednol) 0.2% ophthalmic suspension.
Download PDF
Return to publications
